Market Overview

Thoratec Announces Approval for HeartMate II in Japan

Related THOR
Benzinga's Top Downgrades
Piper Jaffray Downgrades Thoratec To Neutral

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that the company has received approval from Japan's Ministry of Health, Labour and Welfare to market HeartMate IIĀ® ^ as a Bridge-to-Transplantation therapy for patients suffering from advanced heart failure.

Posted-In: News


Related Articles (THOR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters